EGFR and breast carcinoma: Furthermore, the hypoxic transcription factor of EGFR suppresses specific tumor suppressor-like miRNA maturation through phosphorylation of AGO2 involved in the regulation of the RISC [37], thus enhancing cell survival and invasiveness and correlating with poorer overall survival in breast cancer patients.